Clonal haematopoiesis of indeterminate potential and incident cardiovascular disease in individuals with MASLD

Background The impact of clonal haematopoiesis of indeterminate potential (CHIP), a novel cardiovascular risk factor, remains unclear in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), where cardiovascular disease (CVD) is the main cause of mortality. Methods We analysed data from 140,086 UK Biobank participants with MASLD. CHIP was identified via whole-exome sequencing. Incident CVD, including coronary heart disease (CHD), stroke, and heart failure (HF), was the primary outcome. Cox proportional hazards models assessed the association between CHIP and CVD risk. Results During a median 13.5-year follow-up, 15.7% of participants developed CVD. CHIP was associated with a higher risk of CVD (HR: 1.16, 95% CI: 1.09–1.23), with higher risks of stroke (HR: 1.22, 95% CI: 1.07–1.38) and HF (HR: 1.34, 95% CI: 1.21–1.49). Mutations in ASXL1, SRSF2, JAK2 , and SF3B1 were associated with a particularly high CVD risk. Additionally, a higher clonal haematopoiesis risk score (CHRS) was associated with incident CVD, CHD, stroke, and HF. In the three-category analysis, the P value for trend was significant for all outcomes, but the association was confined to large CHIP for CVD and CHD, whereas both CHIP categories showed elevated estimates for stroke and HF. Conclusions CHIP is independently associated with incident CVD in patients with MASLD. These findings support prospective evaluation of CHIP-informed cardiovascular risk stratification in this population.

Authors

Institutions

Publication Details

Journal
Frontiers in Cardiovascular Medicine
Published
2026-11-16
DOI
https://doi.org/10.3389/fcvm.2026.1998218
Primary Topic
Acute Myeloid Leukemia Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Clonal haematopoiesis of indeterminate potential and incident cardiovascular disease in individuals with MASLD

Y Y Sun, Feng Tian, Ningjian Wang, Heng Wan et al.
Frontiers in Cardiovascular Medicine
Acute Myeloid Leukemia Research
article

Clonal haematopoiesis of indeterminate potential and incident cardiovascular disease in individuals with MASLD

Y Y Sun, Feng Tian, Ningjian Wang, Heng Wan, Qianyun Wang, Yuefeng Yu, Keyue Yang, Jie Shen, Yijun Lin
article en

Abstract

Background The impact of clonal haematopoiesis of indeterminate potential (CHIP), a novel cardiovascular risk factor, remains unclear in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), where cardiovascular disease (CVD) is the main cause of mortality. Methods We analysed data from 140,086 UK Biobank participants with MASLD. CHIP was identified via whole-exome sequencing. Incident CVD, including coronary heart disease (CHD), stroke, and heart failure (HF), was the primary outcome. Cox proportional hazards models assessed the association between CHIP and CVD risk. Results During a median 13.5-year follow-up, 15.7% of participants developed CVD. CHIP was associated with a higher risk of CVD (HR: 1.16, 95% CI: 1.09–1.23), with higher risks of stroke (HR: 1.22, 95% CI: 1.07–1.38) and HF (HR: 1.34, 95% CI: 1.21–1.49). Mutations in ASXL1, SRSF2, JAK2 , and SF3B1 were associated with a particularly high CVD risk. Additionally, a higher clonal haematopoiesis risk score (CHRS) was associated with incident CVD, CHD, stroke, and HF. In the three-category analysis, the P value for trend was significant for all outcomes, but the association was confined to large CHIP for CVD and CHD, whereas both CHIP categories showed elevated estimates for stroke and HF. Conclusions CHIP is independently associated with incident CVD in patients with MASLD. These findings support prospective evaluation of CHIP-informed cardiovascular risk stratification in this population.

Frontiers in Cardiovascular MedicineVol. 13
Shanghai Ninth People's Hospital (CN), The First People's Hospital of Shunde (CN), Shanghai Pudong New Area Gongli Hospital (CN)
Southern Medical University
Good health and well-being
Acute Myeloid Leukemia Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon